Status:

RECRUITING

Integrative Breathwork Intervention for Chronic Pain

Lead Sponsor:

University of Florida

Collaborating Sponsors:

National Center for Complementary and Integrative Health (NCCIH)

Conditions:

Chronic Low-back Pain

Eligibility:

All Genders

18-70 years

Phase:

PHASE1

PHASE2

Brief Summary

The proposed research is to develop and refine a multicomponent breathwork intervention, Guided Respiration Mindfulness Therapy, and to iteratively evaluate its feasibility, acceptability, and plausib...

Detailed Description

Multiple single-arm iterations of an 8-week breathwork intervention will be conducted to refine and optimize the intervention and protocol. Upon completion of each iteration, quantitative and qualitat...

Eligibility Criteria

Inclusion

  • Men and women 18-70 years of age.
  • Chronic primary low back pain that has persisted for at least 3 months and on most days for the past 6 months.
  • Average pain intensity of ≥ 4/10 for the past month.
  • Fluent in English.
  • Access to internet with a valid email address.
  • Able to lay down and stay relatively still for one hour.

Exclusion

  • Leg pain, or any other chronic pain, that is greater than low back pain.
  • Back pain possibly due to specific conditions (e.g., cancer, infection).
  • Ongoing legal action or disability claim related to low back pain.
  • Neurological symptoms associated with low back pain, including loss of control or incontinence of bowel or bladder.
  • Systemic rheumatic disease/condition (e.g. rheumatoid arthritis, systemic lupus erythematosus, fibromyalgia).
  • Respiratory disorder (e.g., chronic obstructive pulmonary disease) or moderate to severe asthma within the past 12 months.
  • Activity limiting heart disease including cardiovascular or peripheral arterial disease.
  • Uncontrolled hypertension (i.e. SBP/DBP of \> 160/95) or orthostatic hypotension (e.g., issues with fainting).
  • Neurological disease (e.g. Parkinson's, multiple sclerosis, epilepsy, history of seizures) or evidence of previous brain injury, including stroke and traumatic brain injury.
  • Serious acute physical injuries or any surgery within the past 6 months.
  • Serious psychiatric disorder (e.g., schizophrenia) or mental health issues requiring hospitalization within the past 12 months or currently on anti-psychotic medications.
  • History of hospitalization or treatment of substance use disorder within the past 12 months.
  • Currently undergoing curative or palliative chemotherapy or radiation. Pregnant or plan to become pregnant during the study period.
  • Glaucoma or detached retina.
  • Current participation or participation in the past 2 months of an interventional research study.
  • Cognitive impairment or factors that would preclude comprehension of material and/or full participation in the study.

Key Trial Info

Start Date :

October 24 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 22 2027

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06546956

Start Date

October 24 2024

End Date

May 22 2027

Last Update

November 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Florida

Gainesville, Florida, United States, 32610